Search
fosaprepitant (Emend)
Indications:
- chemotherapy-induced nausea/vomiting
Dosage: 150 mg weekly IV infusion [2]
Mechanism of action:
- prodrug of aprepitant
Notes: Manufacturer: Merk
Related
aprepitant (Emend)
General
anti-emetic
Database Correlations
PUBCHEM correlations
References
- Prescriber's Letter 16(2): 2009
New Drugs Approved by the FDA in 2008
Detail-Document#: 250213
(subscription needed) http://www.prescribersletter.com
- Yang Q, Zou X, Xie YL et al
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent
Chemoradiotherapy-Induced Nausea and Vomiting. A Pilot Randomized Clinical Trial.
JAMA Netw Open. 2023;6(7):e2326127. July 27
PMID: 37498596
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807658